Case report: Dupilumab-induced linear psoriasis: a rare presentation

Case report: Dupilumab-induced linear psoriasis: a rare presentation

A 42 year-old male with prurigo nodularis treated with dupilumab showed a case of linear psoriasis, highlighting the potential of dupilumab to induce immune shift and chimeric gene expression.

Saved in:

Bibliographic Details
Main Authors:	Wen Sun, Kexin Wang, Yuekang Ren, Huajie Yuan, Xiaoqing Lang, Shuping Guo, Hongye Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Medicine
Subjects:	dupilumab linear psoriasis prurigo nodularis case report chimeric gene
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2024.1527257/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Epidemiology of prurigo nodularis: An analysis of global trends from 1998–2023
by: Shiyan Yang, et al.
Published: (2025-01-01)

Dupilumab in children with eosinophilic esophagitis: a retrospective multicenter study
by: Mohammed Hasosah, et al.
Published: (2025-02-01)

Successful Treatment of Linear Psoriasis With the IL-17a-Antagonist Ixekizumab: A Case Report
by: Christov S, et al.
Published: (2025-01-01)

Tumors in the setting of dupilumab use: A review of the literature
by: Shumeng Guo, et al.
Published: (2025-01-01)

Effectiveness of dupilumab treatment against refractory eosinophilic chronic rhinosinusitis
by: Daiki Nakashima, MD, et al.
Published: (2025-05-01)

Unstable psoriasis in the setting of psoriatic arthritis: A rare presentation
by: Roma Raj, et al.
Published: (2022-01-01)

Effect of dupilumab on otitis media associated with eosinophilic chronic rhinosinusitis
by: Seiichiro Kamimura, et al.
Published: (2025-03-01)

Adalimumab induced psoriasis in Crohn’s disease and treatment with ustekinumab: case report and special histopathological findings
by: Fang Qiu, et al.
Published: (2025-01-01)

Dupilumab for treatment of primary cutaneous amyloidosis in adults: two case reports and literature review
by: Feiying Guo, et al.
Published: (2025-02-01)

Canadian real-world study of access and clinical results using dupilumab for chronic rhinosinusitis with polyps
by: Shaun J. Kilty, et al.
Published: (2022-04-01)

Effectiveness and Safety of Dupilumab and Tralokinumab for Treating Atopic Dermatitis and Pruritic Skin Disorders in Oncological Patients: A Narrative Review
by: Lauletta G, et al.
Published: (2025-01-01)

Dupilumab-induced serum sickness-like reaction in a pediatric patient
by: S. Minhaj Rahman, BA, et al.
Published: (2025-02-01)

Predicting dupilumab effectiveness with Type-2 biomarkers: A real-world study of severe asthma
by: Kenji Mizumura, et al.
Published: (2025-01-01)

Real-world efficacy and safety of dupilumab in children with atopic dermatitis under 6 years of age: a retrospective multicentric study
by: Filip Rob, et al.
Published: (2025-12-01)

Safety of dupilumab in Chinese pediatric patients aged 6 months and older: a prospective real-world study
by: Yanhua Chen, et al.
Published: (2025-01-01)

Case report: Advanced age at transplantation and pre-emptive treatment with dupilumab in DOCK8 deficiency
by: Sophia Trombello, et al.
Published: (2025-01-01)

Rosacea-like skin reaction under treatment with dupilumab for atopic dermatitis
by: C. Grote, et al.
Published: (2025-12-01)

Eosinophilic esophagitis in the “atopic march”: dupilumab as an “umbrella” strategy for multiple coexisting atopic diseases
by: Nicola Lutzu, et al.
Published: (2025-01-01)

Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis
by: Tiago Torres, et al.
Published: (2024-04-01)

A Rare Case of Prurigo Pigmentosa in Iranian Sibling Couple
by: Saman Al‐Zahawi, et al.
Published: (2025-01-01)

The Association of Inflammatory Indexes Derived from Peripheral Blood Cell Count and Clinical Signs with Response to Treatment with Dupilumab in Pediatric Patients with Moderate-to-Severe Atopic Dermatitis
by: Zhang L, et al.
Published: (2025-01-01)

Long-term effects of dupilumab on chronic rhinosinusitis with nasal polyps: A step towards clinical remission
by: Mona Al-Ahmad, MD, FRCPC, et al.
Published: (2025-02-01)

Efficacy of dupilumab with concomitant topical calcineurin inhibitors treatment for preschool children with atopic dermatitis: a retrospective cohort study
by: Wu Liming, et al.
Published: (2025-12-01)

A real-world study to assess the disease control of moderate to severe atopic dermatitis in patients receiving dupilumab therapy, with atopic dermatitis control tool in Gulf countries
by: Amani Alfalasi, et al.
Published: (2025-12-01)

Depression and anxiety among psoriasis patients
by: Hojat Eftekhari, et al.
Published: (2024-11-01)

Pediatric Psoriasis: A Comprehensive Review with a Focus on the Latest Therapeutic Updates
by: Vineet Relhan, et al.
Published: (2024-12-01)

Aspectos psicológicos para el manejo de la psoriasis
by: Rubén Pérez Armas, et al.
Published: (2013-10-01)

Beyond the dichotomy: understanding the overlap between atopic dermatitis and psoriasis
by: Mengmeng Li, et al.
Published: (2025-02-01)

Drug-induced psoriasis
by: Sunil Dogra, et al.
Published: (2019-01-01)

Case report: Atopic dermatitis-like skin manifestations in hypohidrotic ectodermal dysplasia caused by a novel splice site mutation of the EDA gene successfully treated with dupilumab
by: Eri Uchiyama, et al.
Published: (2025-01-01)

Geriatric Psoriasis: Evaluation of Clinical Features, Disease Course, and Treatment Modalities of Patients from a Tertiary Care Hospital
by: Elif Çalışkan, et al.
Published: (2025-01-01)

CONDITIONS OF SKIN AND INTESTINE MICROBIOTES IN PATIENTS WITH PSORIASIS
by: Ya.O. Yemchenko, et al.
Published: (2022-04-01)

Efficacy and safety of ustekinumab in the treatment of moderate to severe plaque psoriasis in Singapore
by: Wai Sze Agnes Chan, et al.
Published: (2023-07-01)

Cardiovascular Complications During Delivery Hospitalization in Patients With Psoriasis
by: Ankit Agrawal, MD, et al.
Published: (2025-02-01)

New horizons in the treatment of psoriasis: Modulation of gut microbiome
by: Mojtaba Memariani, et al.
Published: (2025-01-01)

Managing pediatric psoriasis: update on treatments and challenges—a review
by: A. A. Hebert, et al.
Published: (2022-07-01)

Case report: Successful treatment with spesolimab of acrodermatitis continua of Hallopeau in an older patient without IL36RN mutations
by: Jianfeng Zheng, et al.
Published: (2025-01-01)

Skin Metabolic Signatures of Psoriasis and Psoriasis Concurrent with Metabolic Syndrome
by: Yan L, et al.
Published: (2025-01-01)

Case Report: Severe ophiasis-pattern alopecia areata with concomitant atopic dermatitis in a 5-year-old boy successfully treated with dupilumab
by: Zhendong Wei, et al.
Published: (2025-02-01)

Comparison of Mean Platelet Volume (MPV) in Patients with Psoriasis and Healthy Individuals
by: Komal Shehzade, et al.
Published: (2025-01-01)